1
|
Armstrong ND, Srinivasasainagendra V, Chekka LMS, Nguyen NHK, Nahid NA, Jones AC, Tanner RM, Hidalgo BA, Limdi NA, Claas SA, Gong Y, McDonough CW, Cooper-DeHoff RM, Johnson JA, Tiwari HK, Arnett DK, Irvin MR. Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. Genes (Basel) 2022; 13:1260. [PMID: 35886043 PMCID: PMC9319619 DOI: 10.3390/genes13071260] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Revised: 07/01/2022] [Accepted: 07/07/2022] [Indexed: 02/05/2023] Open
Abstract
Hypertension is a leading risk factor for cardiovascular disease mortality. African Americans (AAs) have the highest prevalence of hypertension in the United States, and to alleviate the burden of hypertension in this population, better control of blood pressure (BP) is needed. Previous studies have shown considerable interpersonal differences in BP response to antihypertensive treatment, suggesting a genetic component. Utilizing data from 4297 AA participants randomized to chlorthalidone from the Genetics of Hypertension Associated Treatments (GenHAT) study, we aimed to identify variants associated with the efficacy of chlorthalidone. An additional aim was to find variants that contributed to changes in fasting glucose (FG) in these individuals. We performed genome-wide association analyses on the change of systolic and diastolic BP (SBP and DBP) over six months and FG levels over 24 months of treatment. We sought replication in the International Consortia of Pharmacogenomics Studies. We identified eight variants statistically associated with BP response and nine variants associated with FG response. One suggestive LINC02211-CDH9 intergenic variant was marginally replicated with the same direction of effect. Given the impact of hypertension in AAs, this study implies that understanding the genetic background for BP control and glucose changes during chlorthalidone treatment may help prevent adverse cardiovascular events in this population.
Collapse
Affiliation(s)
- Nicole D. Armstrong
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (N.D.A.); (A.C.J.); (R.M.T.); (B.A.H.)
| | - Vinodh Srinivasasainagendra
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (V.S.); (H.K.T.)
| | - Lakshmi Manasa S. Chekka
- Division of Applied Regulatory Sciences, Center for Drug Evaluation and Research, Silver Spring, MD 20903, USA;
| | - Nam H. K. Nguyen
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
| | - Noor A. Nahid
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
| | - Alana C. Jones
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (N.D.A.); (A.C.J.); (R.M.T.); (B.A.H.)
- Medical Scientist Training Program, University of Alabama at Birmingham, Birmingham, AL 35294, USA
| | - Rikki M. Tanner
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (N.D.A.); (A.C.J.); (R.M.T.); (B.A.H.)
| | - Bertha A. Hidalgo
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (N.D.A.); (A.C.J.); (R.M.T.); (B.A.H.)
| | - Nita A. Limdi
- Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294, USA;
| | - Steven A. Claas
- Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 40506, USA; (S.A.C.); (D.K.A.)
| | - Yan Gong
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
| | - Caitrin W. McDonough
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
| | - Rhonda M. Cooper-DeHoff
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
- Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32611, USA
| | - Julie A. Johnson
- Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA; (N.H.K.N.); (N.A.N.); (Y.G.); (C.W.M.); (R.M.C.-D.); (J.A.J.)
- Division of Cardiovascular Medicine, Department of Medicine, University of Florida, Gainesville, FL 32611, USA
| | - Hemant K. Tiwari
- Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (V.S.); (H.K.T.)
| | - Donna K. Arnett
- Department of Epidemiology, College of Public Health, University of Kentucky, Lexington, KY 40506, USA; (S.A.C.); (D.K.A.)
- Deans Office, College of Public Health, University of Kentucky, Lexington, KY 40506, USA
| | - Marguerite R. Irvin
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA; (N.D.A.); (A.C.J.); (R.M.T.); (B.A.H.)
| |
Collapse
|
2
|
Zhang L, Sun Y, Zhang X, Shan X, Li J, Yao Y, Shu Y, Lin K, Huang X, Yang Z, Chu J, Huang L, Sun H. Three Novel Genetic Variants in the FAM110D, CACNA1A, and NLRP12 Genes Are Associated With Susceptibility to Hypertension Among Dai People. Am J Hypertens 2021; 34:874-879. [PMID: 33621312 DOI: 10.1093/ajh/hpab040] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 01/17/2021] [Accepted: 02/22/2021] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND Although the genetic factors associated with hypertension remain unknown, genetic variations in genes related to ion channels, inflammation, and the cell cycle may affect susceptibility to hypertension. In the present study, the association between hypertension and 10 candidate single-nucleotide polymorphisms (SNPs) was evaluated among Chinese Dai people, who have a smaller gene pool than Han individuals. METHODS A total of 1,193 samples from Dai people were collected, including 488 with hypertension and 705 with normal blood pressure. Based on the preliminary results of whole-genome sequencing among pools of individuals (Pool-seq), 10 candidate SNPs in 6 genes (FAM110D, ADD1, RAG1, CACNA1C, CACNA1A, and NLRP12) were genotyped in the case and control groups by multiplex PCR for SNP genotyping with next-generation sequencing (MultiPCR-NGS). The relationship between hypertension and each candidate SNP was evaluated using the χ 2 test and multiple logistic regression analysis. RESULTS The χ 2 test showed that the allele frequencies of rs3748856 in FAM110D, rs139118504 in CACNA1A, and rs34436714 in NLRP12 were significantly different between the case and control groups (P < 0.005). After adjusting for age, body mass index, total cholesterol, triglyceride, and low-density lipoprotein, logistic regression analyses revealed that the association between the 3 SNPs and hypertension among Dai people remained significant (P = 0.012, 2.71 × 10-4, and 0.017, respectively). CONCLUSIONS These findings indicate that there may be different molecular pathogeneses of hypertension among Dai people, which should be noted in future studies.
Collapse
Affiliation(s)
- Lin Zhang
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Yun Sun
- Yunnan Key Laboratory of Southern Medicinal Resource, College of Traditional Chinese Medicine, Yunnan University of Chinese Medicine, Kunming, China
| | - Xiaochao Zhang
- Key Laboratory of Pharmacology for Natural Products of Yunnan Province, Pharmaceutical College, Kunming Medical University, Kunming, Yunnan, China
| | - Xiyun Shan
- The Department of clinical laboratory, People’s Hospital of Xishuangbanna Dai Autonomous Prefecture, Kunming University of Science and Technology, Xishuangbanna, China
| | - Jianmei Li
- The Cardiovascular Department, The Second People’s Hospital of Yunnan Province, Affiliated Hospital of Yunnan University, Kunming, China
| | - Yao Yao
- The Department of clinical laboratory, People’s Hospital of Xishuangbanna Dai Autonomous Prefecture, Kunming University of Science and Technology, Xishuangbanna, China
| | - Yun Shu
- The Department of clinical laboratory, People’s Hospital of Xishuangbanna Dai Autonomous Prefecture, Kunming University of Science and Technology, Xishuangbanna, China
| | - Keqin Lin
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Xiaoqin Huang
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Zhaoqing Yang
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Jiayou Chu
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Lifan Huang
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Hao Sun
- The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| |
Collapse
|
3
|
Prashanth G, Vastrad B, Tengli A, Vastrad C, Kotturshetti I. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules. BMC Endocr Disord 2021; 21:80. [PMID: 33902539 PMCID: PMC8074411 DOI: 10.1186/s12902-021-00718-5] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2020] [Accepted: 03/02/2021] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. METHODS To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. RESULTS A total of 820 DEGs were identified between healthy obese and metabolically unhealthy obese, among 409 up regulated and 411 down regulated genes. The GO enrichment analysis results showed that these DEGs were significantly enriched in ion transmembrane transport, intrinsic component of plasma membrane, transferase activity, transferring phosphorus-containing groups, cell adhesion, integral component of plasma membrane and signaling receptor binding, whereas, the REACTOME pathway enrichment analysis results showed that these DEGs were significantly enriched in integration of energy metabolism and extracellular matrix organization. The hub genes CEBPD, TP73, ESR2, TAB1, MAP 3K5, FN1, UBD, RUNX1, PIK3R2 and TNF, which might play an essential role in obesity associated type 2 diabetes mellitus was further screened. CONCLUSIONS The present study could deepen the understanding of the molecular mechanism of obesity associated type 2 diabetes mellitus, which could be useful in developing therapeutic targets for obesity associated type 2 diabetes mellitus.
Collapse
Affiliation(s)
- G Prashanth
- Department of General Medicine, Basaveshwara Medical College, Chitradurga, Karnataka, 577501, India
| | - Basavaraj Vastrad
- Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka, 582103, India
| | - Anandkumar Tengli
- Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru and JSS Academy of Higher Education & Research, Mysuru, Karnataka, 570015, India
| | - Chanabasayya Vastrad
- Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad, Karnataka, 580001, India.
| | - Iranna Kotturshetti
- Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka, 582209, India
| |
Collapse
|
4
|
Zhang H, Pushkarev B, Zhou J, Mu Y, Bolshakova O, Shrestha S, Wang N, Jian B, Jin M, Zhang K, Cong M, Liu J, Vitkovsky Y, Qiu C. CACNA1C rs1006737 SNP increases the risk of essential hypertension in both Chinese Han and ethnic Russian people of Northeast Asia. Medicine (Baltimore) 2021; 100:e24825. [PMID: 33663102 PMCID: PMC7909128 DOI: 10.1097/md.0000000000024825] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2020] [Accepted: 01/27/2021] [Indexed: 01/05/2023] Open
Abstract
Voltage-gated Ca2+ channels play a key role in the regulation of arterial tone and blood pressure. The aim of this study was to determine whether the association of calcium voltage-gated channel subunit alpha1 C (CACNA1C) rs1006737 with essential hypertension (EH) exists in both Chinese Han and ethnic Russian populations of Northeast Asia. We used a case-control study of 2 ethnic groups in the same latitude geographical area to investigate the association between the susceptibility of EH and rs1006737 polymorphism. A total of 1512 EH patients and 1690 controls in Chinese Han people (Heilongjiang Provence, China), 250 EH patients, and 250 controls in ethnic Russian people (Chita, Russia), participated in this study. All participants were genotyped using the TaqMan SNP genotyping assay (Agena Company). Baseline characteristics and the minor allele frequencies of rs1006737 vary substantially among common Chinese Han and ethnic Russian people. Allele A was found to be a risk factor for EH in Chinese Han [(odds ratio) OR 1.705, (confidence interval) 95% CI: 1.332-2.182, P < .001] and ethnic Russian (OR 1.437; 95% CI: 1.110-1.860, P = .006). The GA genotype was significantly associated with an increased risk of hypertension (OR 1.538, 95% CI: 1.188-1.991, P = .001) for Chinese Han people, and the AA genotype (OR 2.412, 95% CI: 1.348-4.318, P = .003) for ethnic Russian people. The results of this study indicate that the A allele of the variant rs1006737 in the CACNA1C gene may be a useful genetic marker for EH risk prediction in Chinese Han and ethnic Russian populations.
Collapse
Affiliation(s)
- Hao Zhang
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Boris Pushkarev
- Chita State Medical Academy, 39a Gorky Street, Chita, Russian Federation
| | - Jiexin Zhou
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Yuyuan Mu
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Olga Bolshakova
- Chita State Medical Academy, 39a Gorky Street, Chita, Russian Federation
| | - Sandeep Shrestha
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Ningning Wang
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Baiyu Jian
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Ming Jin
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Keyong Zhang
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Mingyu Cong
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Jicheng Liu
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
| | - Yuri Vitkovsky
- Chita State Medical Academy, 39a Gorky Street, Chita, Russian Federation
| | - Changchun Qiu
- Institute of Polygenic Disease, Qiqihar Medical University, No. 333 Bukui Street, Jianhua District, Qiqihar, Heilongjiang Province , PR China
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences Peking Union Medical College (CAMS/PUMC), Beijing, PR China
| |
Collapse
|
5
|
Huang L, Chu Y, Huang X, Ma S, Lin K, Huang K, Sun H, Yang Z. Association between gene polymorphisms of voltage-dependent Ca 2+ channels and hypertension in the Dai people of China: a case-control study. BMC MEDICAL GENETICS 2020; 21:44. [PMID: 32111194 PMCID: PMC7049211 DOI: 10.1186/s12881-020-0982-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/05/2019] [Accepted: 02/20/2020] [Indexed: 12/24/2022]
Abstract
BACKGROUND Abnormal calcium homeostasis related to the development of hypertension. As the key regulator of intracellular calcium concentration, voltage-dependent calcium channels (VDCCs), the variations in these genes may have important effects on the development of hypertension. Here we evaluate VDCCs variability with respect to hypertension in the Dai ethnic group of China. METHODS A total of 1034 samples from Dai individuals were collected, of which 495 were used as cases, and 539 were used as controls. Blood pressure was measured using a standard mercury measurement method, three times with a rest for 5 min, and the average was used for analyses. Seventeen single nucleotide polymorphisms (SNPs) in the four protein-coding genes (CACNA1A, CACNA1C, CACNA1S, CACNB2) of VDCCs were identified by multiplex PCR-SNP typing technique. Chi-square tests and regression models were used to analyse the associations of SNPs with hypertension. RESULTS The results of chi-square tests showed that the allele frequencies of 5 SNPs were significantly different between the case and the control groups (P < 0.05), but the statistical significance was lost after Bonferroni's correction. However, after adjusting for BMI, age, sex and other factors by logistic regression analyses, the results showed that 5 SNPs consistent with chi-square tests (rs2365293, rs17539088, rs16917217, rs61839222 and rs10425859) were still statistically positive. CONCLUSIONS This finding suggested that the significant association of these SNPs with hypertension may be noteworthy in future studies.
Collapse
Affiliation(s)
- Lifan Huang
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Yan Chu
- Department of General Surgery of the 2nd People Hospital of Yunnan Province, Kunming, China
| | - Xiaoqin Huang
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Shaohui Ma
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Keqin Lin
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Kai Huang
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China
| | - Hao Sun
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
| | - Zhaoqing Yang
- Institute of Medical Biology Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
| |
Collapse
|
6
|
Wu YX, Han X, Chen C, Zou LX, Dong ZC, Zhang YL, Li HH. Time Series Gene Expression Profiling and Temporal Regulatory Pathway Analysis of Angiotensin II Induced Atrial Fibrillation in Mice. Front Physiol 2019; 10:597. [PMID: 31191333 PMCID: PMC6548816 DOI: 10.3389/fphys.2019.00597] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2019] [Accepted: 04/26/2019] [Indexed: 11/24/2022] Open
Abstract
Background/Aim: Angiotensin II (Ang II) and hypertension play critical roles in the pathogenesis of the atrial remodeling that contributes to atrial fibrillation (AF). However, the gene expression profiles and signaling pathways in atria during the development of AF induced by Ang II remain unknown. Methods: Wild-type male mice (C57BL/6 background, 10 weeks old) were administered an infusion of Ang II (2000 ng/kg/min) using an osmotic pump for 1, 2, and 3 weeks. Blood pressure (BP) was measured by the tail-cuff method. AF was induced and recorded. Atrial enlargement and remodeling were examined by echocardiography and Masson’s trichrome staining. Time-series microarray analyses were conducted to examine gene expression profiles and pathways. Results: Ang II infusion resulted in marked elevation of systolic BP, increased AF incidence and duration, atrial enlargement, fibrosis, and atrial infiltration of myofibroblasts and F4/80-positive macrophages in a time-dependent manner. Microarray results showed that 1,719 genes were differentially expressed in the atrium at weeks 1, 2, and 3 after Ang II infusion. Gene ontology showed that these genes participate mainly in immune system processes, and regulation of cell migration, cell adhesion, complement activation, and the inflammatory response. Significant pathways included lysosomal and phagosomal pathways, which are involved in antigen processing and presentation, as well as chemokine signaling, and extracellular matrix–receptor interaction, which are known to play important roles in Ang II-induced AF. Moreover, these differentially expressed genes were classified into 50 profiles by hierarchical cluster analysis. Of these, eight profiles were significant and contained a total of 1,157 genes. Gene co-expression network analysis identified that Pik3cg (also known as phosphoinositide-3-kinase regulatory subunit 3) was localized in the core of the gene network, and was the most highly expressed among the Pik3 isoforms at different time points. Conclusion: The present findings revealed that many genes are involved in Ang II-induced AF, and highlighted that Pik3cg may play a central role in this disease.
Collapse
Affiliation(s)
- Yu-Xuan Wu
- Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.,Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| | - Xiao Han
- Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| | - Chen Chen
- Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| | - Lei-Xin Zou
- Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| | - Zhi-Chao Dong
- Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China
| | - Yun-Long Zhang
- Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.,Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| | - Hui-Hua Li
- Department of Cardiology, Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.,Department of Nutrition and Food Hygiene, School of Public Health, Dalian Medical University, Dalian, China
| |
Collapse
|
7
|
Wang N, Li X, Zhang Q, Zhang H, Zhou L, Wu N, Jin M, Qiu C, Zhang K. Association of angiotensin-converting enzyme gene polymorphism with pulse pressure and its interaction with obesity status in Heilongjiang province. Clin Exp Hypertens 2018; 41:70-74. [DOI: 10.1080/10641963.2018.1445749] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- Ningning Wang
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Xueyan Li
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Qi Zhang
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Hao Zhang
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Li Zhou
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Nan Wu
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Ming Jin
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| | - Changchun Qiu
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
- Department of Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China
| | - Keyong Zhang
- Institute of Polygenic Disease, Qiqihar Medical University, Qiqihar, Heilongjiang, China
| |
Collapse
|